Progressive lipodystrophy
Progressive lipodystrophy is a rare autonomic nervous system disease characterized by impaired adipose tissue metabolism. Its clinical and histological features are slowly progressive, bilaterally distributed, basically symmetrical, well-defined, atrophy or disappearance of subcutaneous adipose tissue, sometimes combined with localized adipose tissue hyperplasia and hypertrophy. Due to the different ranges of fat atrophy, it can be divided into localized lipodystrophy (Simons disease or head and chest lipodystrophy) and systemic lipodystrophy (Seip-Laurence syndrome).
-
Site of disease:
Craniospinal cord skin -
Infectious :
Not contagious -
Frequent population:
Females aged 5 to 10 years -
Related symptoms:
Loose and wrinkled skin diabetes whole body emaciation type lower body emaciation type excessive fat accumulation in liver cells -
Concurrent disease:
Related Drugs
Insulin injection
Indication: 1. Type Ⅰ diabetes; 2. Type Ⅱ diabetes with severe infection, trauma, major surgery and other severe stress situations, as well as cardiovascular and cerebrovascular complications, kidney or retinal diseases; 3. Diabetic ketoacidosis, hyperglycemia non-ketotic hyperosmolar coma; 4. Long-term type Ⅱ diabetes with indeed low plasma insulin levels, which are not satisfactorily controlled by reasonable diet, physical activity and oral hypoglycemic drugs, and type Ⅱ diabetes with contraindications to oral hypoglycemic drugs, such as pregnancy and breastfeeding; 5. Adult or elderly diabetic patients with acute onset, significant weight loss and obvious emaciation; 6. Gestational diabetes; 7. Diabetes secondary to severe pancreatic disease; 8. For severe malnutrition, emaciation, intractable vomiting during pregnancy, and early stage of cirrhosis, glucose and small doses of insulin can be given intravenously at the same time to promote tissue utilization of glucose.
Manufacturer:
Anhui Hongye Pharmaceutical Co., Ltd.
Related Ingredients